CLORHIDRAT DE SEVELAMER WAYMADE 800mg tablets medication leaflet

V03AE02 sevelamer • Various | All other therapeutic products | Drugs for treatment of hyperkalemia and hyperphosphatemia

Sevelamer is a medication used to control hyperphosphatemia in patients with chronic kidney disease on dialysis. It works by binding to dietary phosphates in the gastrointestinal tract, reducing their absorption and serum phosphate levels.

The medication is taken orally, as directed by a doctor, usually with meals. It is important for patients to follow the treatment regimen and adhere to a low-phosphate diet.

Patients should be aware of potential side effects, such as gastrointestinal disturbances, nausea, or constipation. It is important to inform the doctor of any unusual symptoms.

Common side effects include gastrointestinal disturbances, nausea, and constipation. In rare cases, severe reactions such as intestinal obstruction or gastrointestinal perforation may occur. Patients should be informed of these risks before starting treatment.

General data about CLORHIDRAT DE SEVELAMER WAYMADE 800mg

Substance: sevelamer

Date of last drug list: 01-06-2025

Commercial code: W67199003

Concentration: 800mg

Pharmaceutical form: tablets

Quantity: 180

Product type: generic

Price: 513.64 RON

Prescription restrictions: P-RF - Medicines prescription that is retained in the pharmacy (not renewable).

Marketing authorisation

Manufacturer: WAYMADE PLC - MAREA BRITANIE

Holder: WAYMADE B.V. - OLANDA

Number: 12625/2019/03

Shelf life: 4 years

Pharmaceutical forms available for sevelamer

Concentrations available for sevelamer

1.6g, 2.4g, 400mg, 403mg, 800mg

Compensation lists for CLORHIDRAT DE SEVELAMER WAYMADE 800mg WAYMADE B.V.

NHP 10 (C2) - Replacement of renal function in patients with chronic renal failure

Price

Copayment

Patient

513.64 RON

455.45 RON

58.19 RON